相似文献
1
Clinical relevance of nontuberculous Mycobacteria, Oman.
Emerg Infect Dis. 2009 Feb;15(2):292-4. doi: 10.3201/eid1502.080977.
2
Nontuberculous mycobacteria isolated from specimens of pulmonary tuberculosis suspects, Northern Tunisia: 2002-2016.
BMC Infect Dis. 2019 Sep 18;19(1):819. doi: 10.1186/s12879-019-4441-1.
3
Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
BMC Infect Dis. 2017 Jun 15;17(1):432. doi: 10.1186/s12879-017-2532-4.
4
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.
J Clin Microbiol. 2009 Dec;47(12):4124-8. doi: 10.1128/JCM.01257-09. Epub 2009 Oct 21.
5
Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India.
J Infect Public Health. 2021 Mar;14(3):320-323. doi: 10.1016/j.jiph.2020.12.027. Epub 2021 Feb 19.
6
Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.
Tuberculosis (Edinb). 2013 Nov;93(6):642-6. doi: 10.1016/j.tube.2013.07.007. Epub 2013 Aug 7.
7
Prevalence and species spectrum of both pulmonary and extrapulmonary nontuberculous mycobacteria isolates at a tertiary care center.
Int J Mycobacteriol. 2016 Sep;5(3):288-293. doi: 10.1016/j.ijmyco.2016.06.008. Epub 2016 Jun 27.
8
The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong.
Respir Med. 1995 Jan;89(1):3-8. doi: 10.1016/0954-6111(95)90063-2.
9
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.
Emerg Infect Dis. 2017 Nov;23(11):1898-1901. doi: 10.3201/eid2311.170959.
10
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
引用本文的文献
1
Clinical Significance, Species Distribution, and Temporal Trends of Nontuberculous Mycobacteria, Denmark, 1991-2022.
Emerg Infect Dis. 2024 Sep;30(9):1755-1762. doi: 10.3201/eid3009.240095.
2
Prevalence of in clinical and environmental isolates, a systematic review and meta-analysis.
Front Microbiol. 2024 Feb 19;15:1321273. doi: 10.3389/fmicb.2024.1321273. eCollection 2024.
3
Screening of Fungi for Antimycobacterial Activity Using a Medium-Throughput Bioluminescence-Based Assay.
Front Microbiol. 2021 Sep 6;12:739995. doi: 10.3389/fmicb.2021.739995. eCollection 2021.
4
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: and .
J Clin Med. 2020 Aug 6;9(8):2541. doi: 10.3390/jcm9082541.
5
Efficacy and Mechanisms of Flavonoids against the Emerging Opportunistic Nontuberculous Mycobacteria.
Antibiotics (Basel). 2020 Jul 27;9(8):450. doi: 10.3390/antibiotics9080450.
6
The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
Drug Des Devel Ther. 2020 Jun 10;14:2287-2294. doi: 10.2147/DDDT.S146111. eCollection 2020.
7
The Rise of Non-Tuberculosis Mycobacterial Lung Disease.
Front Immunol. 2020 Mar 3;11:303. doi: 10.3389/fimmu.2020.00303. eCollection 2020.
8
Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA.
Med Princ Pract. 2019;28(3):208-215. doi: 10.1159/000498910. Epub 2019 Feb 14.
9
Mycobacterium avium Complex Disease.
Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0045-2017.
10
Nontuberculous Mycobacteria in Saudi Arabia and Gulf Countries: A Review.
Can Respir J. 2017;2017:5035932. doi: 10.1155/2017/5035932. Epub 2017 Feb 27.
本文引用的文献
1
Occurrence and clinical relevance of Mycobacterium chimaera sp. nov., Germany.
Emerg Infect Dis. 2008 Sep;14(9):1443-6. doi: 10.3201/eid1409.071032.
2
Lymphadenopathy caused by Mycobacterium colombiense.
J Clin Microbiol. 2008 May;46(5):1885-7. doi: 10.1128/JCM.01441-07. Epub 2008 Feb 27.
3
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Thorax. 2008 Jul;63(7):627-34. doi: 10.1136/thx.2007.087999. Epub 2008 Feb 4.
4
Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand.
Clin Infect Dis. 2007 Aug 15;45(4):421-7. doi: 10.1086/520030. Epub 2007 Jul 5.
5
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
6
Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant.
Int J Syst Evol Microbiol. 2006 Sep;56(Pt 9):2049-2054. doi: 10.1099/ijs.0.64190-0.
7
Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea.
Chest. 2006 Feb;129(2):341-348. doi: 10.1378/chest.129.2.341.
8
Isolation of nontuberculous mycobacteria in Zambia: eight case reports.
J Clin Microbiol. 2005 Dec;43(12):6020-6. doi: 10.1128/JCM.43.12.6020-6026.2005.
9
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.
Int J Tuberc Lung Dis. 2004 Oct;8(10):1186-93.
10
Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov.
Int J Syst Evol Microbiol. 2004 Jul;54(Pt 4):1277-1285. doi: 10.1099/ijs.0.02777-0.
Zotero 插件